featured
Oncological Outcomes After Irreversible Electroporation for the Ablation of Localized Low–Intermediate-Risk Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate Cancer
J Urol 2022 Nov 28;[EPub Ahead of Print], J de la Rosette, J Dominguez-Escrig, K Zhang, J Teoh, E Barret, JC Ramon-Borja, G Muir, J Bohr, T de Reijke, CF Ng, CH Leung, R Sanchez-Salas, P LagunaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.